Product logins

Find logins to all Clarivate products below.


Large-Joint Reconstructive Implants | Market Insights | US | 2019

Demand for better patient outcomes will drive the uptake of novel technologies such as patient-conforming and 3-D printed implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques, supporting the expansion of the US large-joint reconstructive implant market through 2027; however, downward pricing pressures driven by bundled payment initiatives such as the CJR and BPCI Advanced models, growing outpatient joint replacement volumes, and the increasing influence of GPOs will limit overall revenue potential to some degree.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 10-year period.

Related Medtech Insights Reports

Report
Heart Valve Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2019
The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data…
Report
Diabetes Care Devices | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2019
The Asia Pacific diabetes care device market will grow strongly over the forecast period, fueled by the growing number of diabetic patients in the Asia Pacific region. However, the markets—…
Report
Heart Valve Devices | Market Analysis | Europe | 2019
The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data…
Report
Diabetes Care Devices | Medtech 360 | Market Analysis | Asia Pacific | 2019
The Asia Pacific diabetes care device market will grow strongly over the forecast period, fueled by the growing number of diabetic patients in the Asia Pacific region. However, the markets—…
Report
Drug Delivery Devices – Market Insights – United States
The US drug delivery device market will grow moderately through 2027, fueled by growth in patient populations and the approval of biosimilars for drug delivery devices. The opportunities…